NEXO
12.3.2024 17:26:34 CET | Business Wire | Press release
20+ leading crypto organizations including BTC Inc, Bitget, Brink, Chainalysis, Hacken, Nansen, and Unstoppable Domains have come together for the 'Bitcoin Deserves an Emoji' movement, initiated by Nexo. Uniting the global crypto community, the initiative aims to introduce a Bitcoin emoji to any digital keyboard and emphasize cryptocurrency's triple identity as money, technology, and culture in today’s society.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312299831/en/
Uniting the global crypto community, the 'Bitcoin Deserves an Emoji' initiative aims to introduce a Bitcoin emoji to any digital keyboard and emphasize cryptocurrency's triple identity as money, technology, and culture in today’s society. (Graphic: Business Wire)
This community-driven initiative starts with a 50-day petition on Change.org, followed by an official proposal to the Unicode Consortium during the 2024 submission window. The new, widespread effort for a Bitcoin emoji, once turned down in 2020, shows just how important blockchain has become in our daily lives.
Celebrating Community, Culture, and Collective Values
92% of internet users worldwide use emojis in their digital communications, according to Unicode. Originating in Japan in the 1990s, emojis have transformed from niche pictographs to key elements of online conversations, transcending language and borders to reflect our values, innovations, and contemporary culture. Similarly, Bitcoin, beyond being a mere asset, displays the technological breakthrough of blockchain, embodying principles of decentralization, transparency, and security. Its inclusion as an emoji would not only symbolize its indispensable role in today's digital and financial landscapes but also ensure Bitcoin is recognized as an integral part of daily life across the globe.
Voices of the Movement
Already gaining substantial traction, the Bitcoin Emoji Initiative showcases the unity within the cryptocurrency community and the shared goal of further establishing Bitcoin's presence in our cultural landscape.
“Bitcoin's journey reflects a remarkable blend of innovation and community. It's time its significance is recognized universally, starting with a symbol we all understand - an emoji. Join us in making history,” said Kosta Kantchev, Co-founder & Executive Chairman of Nexo.
“Bitcoin is universal money for the world, it needs a universal emoji for every person, young and old to use,” said David Bailey, CEO of BTC Inc.
“Supporting Bitcoin's development has always been about changing the world through code. An official emoji is a nod to Bitcoin's technological impact on the world.” said Mike Schmidt, Executive Director of Brink.
"Bitget recognizes the significance of having a Bitcoin emoji as a universal symbol of digital assets in our everyday communication. This initiative aligns with our mission to promote crypto adoption and accessibility. We wholeheartedly support this endeavor and believe it will contribute further to mainstream acceptance of the whole industry. Together with our partners and the wider crypto community, we are committed to advocating for the inclusion of a Bitcoin emoji on keyboards worldwide,” said Gracy Chen, Managing Director of Bitget.
"We fully support Nexo's petition as this initiative to create a Bitcoin Emoji aligns perfectly with Nansen's commitment to fostering a more inclusive and expressive crypto environment”, said Alex Svanevik, CEO and co-founder of Nansen.
“For a decade, Chainalysis has been dedicated to fostering trust in blockchains while aiding the advancement of the web3 ecosystem and assisting public sector entities in staying abreast of crypto developments. As a trailblazer in blockchain analysis, we've safeguarded and championed Bitcoin since its inception. We commend Nexo's advocacy for acknowledging a cultural symbol—the Bitcoin emoji—a testament to the era we inhabit”, said Ian Andrews, CMO of Chainalysis.
"The definition of an emoji is a small digital image or icon used to express an idea. Bitcoin is now a well-known idea across all countries. CryptoQuant fully supports Nexo's initiative to facilitate the global mass adoption of Bitcoin," said CryptoQuant's CEO Ki Young Ju.
“The Bitcoin emoji reflects the essence of decentralization, representing a collective movement towards a more open and inclusive financial future for everyone. We align with Nexo's Bitcoin Emoji petition,” said Sam Lekhak, Head of Marketing & Comms at Liquity.
“We're thrilled to stand alongside industry leaders in championing a Bitcoin emoji, a move poised to give identity to the industry while also serving as a bridge between technical innovation and cultural expression,” said Sandy Carter, COO, Unstoppable Domains
Join the Movement
Everyone is invited to be part of this historic community-driven initiative. By signing the Change.org petition and advocating for the Bitcoin emoji, everyone can contribute to celebrating Bitcoin's legacy and future. For more information and to join the campaign, visit bitcoinemoji.org.
About the Initiative
This initiative is a collaborative effort by 20+ leading organizations in the cryptocurrency space, united by a common goal to promote understanding, adoption, and technological progress of digital currencies. Participating organizations: Nexo, Brink, Bitget, Chainalysis, Polygon, Brave, BTC Inc, Hacken, CryptoQuant, Nansen, Unstoppable Domains, Liquity, Mara, Busha, Zulu, Cadenza, Bware Labs, Meta4 Capital, Sift, MarketAcross, Bitcompare, Bithomp, Milkroad, Crypto Oasis.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240312299831/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom